English-language podcasts

The Rundown

Nvidia Investigates CEO Over Chinese Spy Affair, Tesla Pulls the Plug on the Cybertruck

12 min

Listen through the publisher, then discuss the episode here or arrange an in-person Roundtable. Your city determines where to meet.

Roundtables are designed for groups of four, with a shared subject and room for everyone to speak. Come for discussion, with no dating expectation.

Market update for November 9, 2026 In today’s episode, Zaid covers: Nvidia’s Board launches investigation into Jensen Huang Constellation Energy’s earnings and the outlook for data-center power demand AMD’s upgrade and a potential opening in the chip race Monday.com’s earnings beat and the forecast that disappointed investors Why Tesla is winding down Cybertruck production

Episode information is provided by the publisher. Listening takes place on the publisher’s service.

Listen at the source ↗

Featured places to meet in Palo Alto, CA

Explore these places and arrange a conversation through ThinkMatch.

City guide for Palo Alto, CA

More from The Rundown

The Rundown

Anthropic Soars in IPO Debut, Walmart Wins Over Wealthier Shoppers

13 min

Market update for November 19, 2026 In today’s episode, Zaid covers: Anthropic’s record IPO and whether its debut can revive the AI rally Walmart’s beats earnings getting boost from higher-income shoppers Palo Alto Networks’ $4.5 billion bet on helping businesses run their own AI models Williams-Sonoma’s selloff after a narrow earnings beat GTA 6’s blockbuster launch and the companies that will benefit from it

Discuss this episode

Community Poll

Sporting success should include character and contribution, not only winning.

Share your view, then see how readers voted. No sign-in required. This poll is shared across stories.

Do you agree or disagree?

Choose one answer

Common Quandary

A Common Quandary to discuss

Another conversation to explore, separate from this news story.

Would you want a doctor to give you a fake pill if the lie might make you feel better?

A patient has persistent symptoms that have not responded to standard treatments. A harmless placebo may help, but its effect could weaken if the clinician fully explains that it contains no active medicine.

Can a beneficial deception respect the person it helps?

Explore this quandary